Emergent Biosolutions
EBS
EBS
232 hedge funds and large institutions have $1.28B invested in Emergent Biosolutions in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 102 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
232
Holders Change
-23
Holders Change %
-9.02%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
64
Reduced
102
Closed
38
Calls
$5.37M
Puts
$1.52M
Net Calls
+$3.84M
Net Calls Change
+$1.59M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$129M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$33.7M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
$60.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$13.9M |
| 5 |
Morgan Stanley
New York
|
$21.7M |
